VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 18 filers reported holding VECTIVBIO HLDG AG in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,880,907 | -1.8% | 2,806,217 | 0.0% | 0.61% | -23.3% |
| Q4 2022 | $24,315,870 | +44.4% | 2,806,217 | 0.0% | 0.80% | +22.9% |
| Q3 2022 | $16,837,000 | +11.1% | 2,806,217 | 0.0% | 0.65% | +15.2% |
| Q2 2022 | $15,154,000 | +14.7% | 2,806,217 | 0.0% | 0.57% | +53.0% |
| Q1 2022 | $13,217,000 | -4.1% | 2,806,217 | 0.0% | 0.37% | +13.1% |
| Q4 2021 | $13,779,000 | -36.4% | 2,806,217 | 0.0% | 0.33% | -34.2% |
| Q3 2021 | $21,678,000 | -33.7% | 2,806,217 | 0.0% | 0.50% | -31.6% |
| Q2 2021 | $32,720,000 | – | 2,806,217 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,675,408 | $13,136,000 | 4.36% |
| Novo Holdings A/S | 3,522,019 | $17,293,000 | 0.82% |
| Cormorant Asset Management, LP | 2,216,763 | $10,884,000 | 0.65% |
| Orbimed Advisors | 5,223,804 | $25,649,000 | 0.33% |
| Bpifrance SA | 2,806,217 | $13,779,000 | 0.33% |
| Eventide Asset Management | 2,339,044 | $11,186,000 | 0.14% |
| Tekla Capital Management LLC | 756,502 | $3,714,000 | 0.12% |
| Pinz Capital Management, LP | 60,094 | $295,000 | 0.11% |
| Canaan Partners XI LLC | 37,051 | $182,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 403,119 | $1,979,000 | 0.02% |